Silverback Therapeutics, Inc. SBTX
5.87 +5.87
Quote time unavailable
Day range unavailable
52-week range unavailable
News
defenseworld.net Head to Head Review: Evelo Biosciences (NASDAQ:EVLO) vs. Silverback Therapeutics (NASDAQ:SBTX) Profitability This table compares Silverback Therapeutics and Evelo Biosciences' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Silverback…
defenseworld.net Silverback Therapeutics (NASDAQ:SBTX) Stock Price Down 4.6% – Here’s What Happened Silverback Therapeutics, Inc. (NASDAQ: SBTX - Get Free Report) was down 4.6% during mid-day trading on Thursday. The company traded as low as $10.00 and last traded at $10.06. Approximately 1,367,808…
proactiveinvestors.co.uk SkinBioTherapeutics receives Croda boost Shares in SkinBioTherapeutics PLC (AIM:SBTX) rose 6% after the company confirmed it had finalised terms with Croda PLC for the commercial launch of its SkinBiotix technology. The agreement includes…
prnewswire.com SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY NEW YORK , Aug. 22, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
prnewswire.com SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates SBTX, IEA, PBFX, RMO NEW YORK , Aug. 15, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
pennystocks.com Penny Stocks To Buy Now? 4 Stocks To Watch Before August Begins Penny stocks to watch right now The post Penny Stocks To Buy Now? 4 Stocks To Watch Before August Begins appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
benzinga.com Silverback Therapeutics Axes Lead Immuno-Oncology Candidates, Lays Off 27% Workforce Silverback Therapeutics Inc (NASDAQ: SBTX) undertakes “strategic realignment,” revealing it would drop its two lead cancer programs and lays off more than a quarter of its staff. Silverback will…- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022 Upgrades
geekwire.com Silverback Therapeutics shuts down oncology program, plans to lay off 27% of workforce Silverback Therapeutics will lay off 27% of its workforce and close its oncology program, the Seattle company announced Thursday in its fourth quarter earnings report.
businesswire.com Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results SEATTLE--(BUSINESS WIRE)--Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically…
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 729 companies set new 52-week lows.
247wallst.com Goldman Sachs Has 5 Buy-Rated Stocks Under $10 With 100% to 600% Upside Potential While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 147 companies achieved new lows for the year.- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 445 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 615 stocks hit new 52-week lows.
accesswire.com CLASS ACTION UPDATE for FB, ONTF and SBTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders NEW YORK, NY / ACCESSWIRE / November 9, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.…
newsfilecorp.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silverback Therapeutics, Inc. - SBTX New York, New York--(Newsfile Corp. - October 1, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silverback Therapeutics, Inc. ("Silverback" or the "Company") (NASDAQ: SBTX).…
newsfilecorp.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silverback Therapeutics, Inc. - SBTX New York, New York--(Newsfile Corp. - September 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silverback Therapeutics, Inc. ("Silverback" or the "Company") (NASDAQ:…
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silverback Therapeutics, Inc. - SBTX NEW YORK, Sept. 19, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silverback Therapeutics, Inc. ("Silverback" or the "Company") (NASDAQ: SBTX).
benzinga.com Silverback Therapeutics Presents Initial Safety Data From Solid Tumor Combo Therapy Trial Silverback Therapeutics Inc (NASDAQ: SBTX) has presented interim data from a Phase 1/1b study of SBT6050 as a monotherapy and in combination with Merck & Co Inc's (NYSE: MRK) Keytruda…
businesswire.com Silverback Therapeutics Presents Interim Clinical Results from the Ongoing Phase 1/1b Study of SBT6050 Alone or In Combination with Pembrolizumab in Patients with Advanced or Metastatic HER2-Expressing Solid Tumors SEATTLE--(BUSINESS WIRE)--Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop…
prnewswire.com SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silverback Therapeutics, Inc. - SBTX NEW YORK, Sept. 14, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silverback Therapeutics, Inc. ("Silverback" or the "Company") (NASDAQ: SBTX).
benzinga.com Why Are Silverback Therapeutics Shares Falling On Monday? Silverback Therapeutics Inc (NASDAQ: SBTX) stock dropped to the lowest level since its IPO in December 2020 in reaction to interim data from SBT6050 Phase 1/1b trial for solid tumors. The trial in…
businesswire.com Silverback Therapeutics to Present Data from its Phase 1/1b Clinical Trial of SBT6050 at the European Society for Medical Oncology (ESMO) 2021 Virtual Congress SEATTLE--(BUSINESS WIRE)--Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop…
businesswire.com Silverback Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference SEATTLE--(BUSINESS WIRE)--Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop…- benzinga.com Stocks That Hit 52-Week Highs On Monday On Monday morning, 415 companies achieved new highs for the year.
benzinga.com Stocks That Hit 52-Week Highs On Friday This morning 150 companies reached new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET on Thursday, 166 companies hit new 52-week highs.
benzinga.com 78 Biggest Movers From Yesterday Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares climbed 115% to close at $2.30 on Monday after declining around 5% on Friday.- benzinga.com 77 Biggest Movers From Friday Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares surged 93.2% to close at $34.78 on Friday after the company priced its IPO at $18 per share.